This webinar will cover an overview of the physiological mechanisms of nasal high flow therapy and the clinical evidence to support its use in key hospital areas.

Webinar Series

This webinar is the first in a series on Nasal High Flow Therapy brought to you through a collaboration between Critical Care Education and Fisher & Paykel Healthcare. Your webinar host Ken Hambrecht will be joined by educators from Fisher & Paykel Healthcare to bring you the latest evidence and clinical application of Nasal High Flow Therapy in various hospital areas.

About this Webinar

In this webinar we will discuss nasal high flow therapy and the unique physiological mechanisms we now know exist, redefining respiratory support.

Numerous physiological parameters are significantly affected in respiratory distress and we look closely at how nasal high flow significantly improves these parameters, in turn relieving respiratory distress.

In addition the webinar will cover the clinical evidence to support the use of nasal high flow in key hospital areas.

Key topics covered:

  • The principles of Humidification and Gas Conditioning
  • The physiological effects of Nasal High Flow Therapy
  • The differences between CPAP and DPAP
  • Aerosolisation of pathogens and current recommendations in the COVID-19 Pandemic

The recording of this webinar is now available online.  You can register in the course to access the recording.

Presented by

Webinar Sponsor

This webinar is sponsored by Fisher & Paykel Healthcare.